Atara Biotherapeutics is a clinical-stage allogeneic (off-the-shelf) T-cell immunotherapy company developing transformative therapies that harness T cells to fight cancer and autoimmune conditions, and is the first company to receive regulatory approval for an allogeneic T-cell immunotherapy. - View it on GitHub